SYK and Alzheimer disease: They demonstrated that SYK is critically involved in the acquisition of DAM in neurodegenerative diseases and that the disruption of this key signalling hub in microglia disruption leads to significant defects in microglia activation, including defective Aβ phagocytosis and delayed proliferation in response to AD-related neuropathology.